CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Expeditors International
EXPD
$16.4B
| $7.35M | 0.07% |
81,187
+69,411
| +589% | +$6.28M |
|
277
Ameresco
AMRC
$1.37B
| $7.24M | 0.07% |
+216,904
| New | +$7.24M |
|
278
VF Corp
VFC
$5.86B
| $7.23M | 0.07% |
102,871
+4,064
| +4% | +$285K |
|
279
Bank of New York Mellon
BK
$73.1B
| $7.23M | 0.07% |
210,407
+35,921
| +21% | +$1.23M |
|
280
State Street
STT
$32B
| $7.18M | 0.07% |
121,014
-2,959
| -2% | -$176K |
|
281
Axsome Therapeutics
AXSM
$6.25B
| $7.16M | 0.07% |
+100,455
| New | +$7.16M |
|
282
HP
HPQ
$27.4B
| $7.14M | 0.07% |
375,748
-36,160
| -9% | -$687K |
|
283
United Rentals
URI
$62.7B
| $7.08M | 0.07% |
40,584
+6,986
| +21% | +$1.22M |
|
284
Vir Biotechnology
VIR
$732M
| $7.06M | 0.07% |
+205,622
| New | +$7.06M |
|
285
West Pharmaceutical
WST
$18B
| $7.05M | 0.07% |
25,657
-5,439
| -17% | -$1.5M |
|
286
Bloom Energy
BE
$13.4B
| $7.02M | 0.07% |
+390,615
| New | +$7.02M |
|
287
Y-mAbs Therapeutics
YMAB
$390M
| $7.01M | 0.07% |
182,704
+17,707
| +11% | +$680K |
|
288
Edwards Lifesciences
EW
$47.5B
| $6.97M | 0.07% |
87,263
-6,574
| -7% | -$525K |
|
|
AERI
289
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.97M | 0.07% |
591,800
| – | – |
|
|
FRC
290
DELISTED
First Republic Bank
FRC
| $6.9M | 0.06% |
63,300
+1,407
| +2% | +$153K |
|
291
Progressive
PGR
$143B
| $6.87M | 0.06% |
72,529
+2,055
| +3% | +$195K |
|
|
MYOV
292
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.84M | 0.06% |
486,864
+265,461
| +120% | +$3.73M |
|
|
QIWI
293
DELISTED
QIWI PLC
QIWI
| $6.83M | 0.06% |
393,800
+10,000
| +3% | +$173K |
|
294
Southwest Airlines
LUV
$16.5B
| $6.82M | 0.06% |
181,978
-461
| -0.3% | -$17.3K |
|
295
Ford
F
$46.7B
| $6.79M | 0.06% |
1,020,108
+751,079
| +279% | +$5M |
|
296
F5
FFIV
$18.1B
| $6.77M | 0.06% |
55,104
+34,647
| +169% | +$4.25M |
|
297
Old Dominion Freight Line
ODFL
$31.7B
| $6.76M | 0.06% |
74,778
-8,780
| -11% | -$794K |
|
298
Williams Companies
WMB
$69.9B
| $6.75M | 0.06% |
343,663
-13,575
| -4% | -$267K |
|
299
Kinder Morgan
KMI
$59.1B
| $6.69M | 0.06% |
542,169
+4,457
| +0.8% | +$55K |
|
300
Schlumberger
SLB
$53.4B
| $6.69M | 0.06% |
429,665
+17,165
| +4% | +$267K |
|